232 related articles for article (PubMed ID: 9397168)
1. A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors.
Gouldson PR; Snell CR; Reynolds CA
J Med Chem; 1997 Nov; 40(24):3871-86. PubMed ID: 9397168
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
Rubenstein LA; Zauhar RJ; Lanzara RG
J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
[TBL] [Abstract][Full Text] [Related]
3. Domain swapping in G-protein coupled receptor dimers.
Gouldson PR; Snell CR; Bywater RP; Higgs C; Reynolds CA
Protein Eng; 1998 Dec; 11(12):1181-93. PubMed ID: 9930667
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
5. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
Simpson LM; Wall ID; Blaney FE; Reynolds CA
Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
7. Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the kappa-opioid receptor. A model for receptor activation.
Paterlini G; Portoghese PS; Ferguson DM
J Med Chem; 1997 Sep; 40(20):3254-62. PubMed ID: 9379445
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
9. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
[TBL] [Abstract][Full Text] [Related]
10. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.
Baldwin JM; Schertler GF; Unger VM
J Mol Biol; 1997 Sep; 272(1):144-64. PubMed ID: 9299344
[TBL] [Abstract][Full Text] [Related]
11. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
Skafar DF; Koide S
Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
[TBL] [Abstract][Full Text] [Related]
12. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
13. Specificity of helix packing in transmembrane dimer of the cell death factor BNIP3: a molecular modeling study.
Vereshaga YA; Volynsky PE; Pustovalova JE; Nolde DE; Arseniev AS; Efremov RG
Proteins; 2007 Nov; 69(2):309-25. PubMed ID: 17600828
[TBL] [Abstract][Full Text] [Related]
14. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
15. Role of the amino acid sequence in domain swapping of the B1 domain of protein G.
Sirota FL; Héry-Huynh S; Maurer-Stroh S; Wodak SJ
Proteins; 2008 Jul; 72(1):88-104. PubMed ID: 18186476
[TBL] [Abstract][Full Text] [Related]
16. Genetic approaches to the determination of structure-function relationships of G protein-coupled receptors.
Strader CD; Sigal IS; Dixon RA
Trends Pharmacol Sci; 1989 Dec; Suppl():26-30. PubMed ID: 2559516
[TBL] [Abstract][Full Text] [Related]
17. The function of the amino terminal domain in NMDA receptor modulation.
Huggins DJ; Grant GH
J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
[TBL] [Abstract][Full Text] [Related]
18. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
19. Binding domain of human parathyroid hormone receptor: from conformation to function.
Pellegrini M; Bisello A; Rosenblatt M; Chorev M; Mierke DF
Biochemistry; 1998 Sep; 37(37):12737-43. PubMed ID: 9737850
[TBL] [Abstract][Full Text] [Related]
20. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
